99 studies found for:    "myoclonic epilepsy myopathy sensory ataxia" OR "Mitochondrial Diseases"
Show Display Options
Rank Status Study
21 Completed Responses to Influenza Vaccine in Patients With Mitochondrial Disorders (MELAS)
Condition: MELAS Syndrome
Intervention: Biological: Intramuscular seasonal trivalent inactivated influenza vaccine
22 Completed Therapy for Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Intervention: Drug: Nutraceuticals
23 Recruiting Natural History Study - Mitochondrial Disease
Condition: Mitochondrial DNA Mutation
Intervention:
24 Recruiting Phase 2 Study of EPI-743 in Children With Pearson Syndrome
Condition: Pearson Syndrome
Intervention: Drug: EPI-743
25 Unknown  Evaluating the Effectiveness of a Dichloroacetate in MELAS Syndrome
Condition: MELAS Syndrome
Intervention: Drug: Dichloroacetate
26 Active, not recruiting Safety and Efficacy Study of EPI-743 in Children With Leigh Syndrome
Condition: Leigh Syndrome
Interventions: Drug: Placebo;   Drug: EPI-743 15 mg/kg;   Drug: EPI-743 5 mg/kg
27 Not yet recruiting PREPL in Health and Disease
Conditions: Hypotonia-Cystinuria Syndrome;   Muscle Hypotonia;   Healthy Volunteers;   Dwarfism, Growth Hormone Deficiency;   Obesity;   Prader-Willi Syndrome
Interventions: Procedure: Blood draw;   Procedure: muscle biopsy
28 Completed Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects
Conditions: Carnitine Palmitoyltransferase II Deficiency;   Very Long Chain Acyl Coa Dehydrogenase Deficiency
Interventions: Drug: Bezafibrate;   Other: Placebo
29 Completed High Protein Diet in Patients With Long-chain Fatty Acid Oxidation Disorders
Conditions: Very Long-chain Acyl-CoA Dehydrogenase Deficiency;   Trifunctional Protein Deficiency;   Carnitine Palmitoyltransferase 2 Deficiency;   Long-chain 3-hydroxyacyl-CoA Dehydrogenase Deficiency
Intervention: Behavioral: Diet counseling
30 Unknown  Assessing Immune Function in Young Patients With Cytopenia That Did Not Respond to Treatment
Conditions: Dyskeratosis Congenita;   Fanconi Anemia;   Myelodysplastic Syndromes;   Nonmalignant Neoplasm;   Pearson Marrow-pancreas Syndrome;   Shwachman-diamond Syndrome
Interventions: Genetic: polymerase chain reaction;   Other: flow cytometry;   Other: immunologic technique;   Procedure: biopsy
31 Recruiting Study of Dapagliflozin on Mitochondrial Dysfunction and Impaired Insulin Signaling/Action
Conditions: Insulin Sensitivity;   Multiple Mitochondrial Dysfunctions Syndrome
Interventions: Drug: Dapagliflozin;   Drug: Placebo
32 Completed Abdominal Adiposity and Muscle Mitochondrial Functions
Condition: Mitochondrial Respiratory Chain Deficiencies
Intervention:
33 Active, not recruiting EPI-743 for Metabolism or Mitochondrial Disorders
Conditions: Metabolic Disease;   Neurology;   Myoptahy
Intervention: Drug: EPI-743
34 Unknown  Chronic Fatigue Syndrome: A Presumptive Mitochondrial Disorder
Condition: Chronic Fatigue Syndrome
Interventions: Drug: Nutraceutical supplements;   Drug: Placebo
35 Completed Mitochondria and Metabolic Syndrome in a Southern California Chinese Cohort
Conditions: Metabolic Syndrome;   Type 2 Diabetes Mellitus
Intervention: Device: Diffuse Optical Spectroscopy
36 Recruiting Safety Evaluation of Gene Therapy in Leber Hereditary Optic Neuropathy (LHON) Patients
Condition: Leber Hereditary Optic Neuropathy
Intervention: Genetic: GS010
37 Recruiting Safety and Efficacy Study of rAAV2-ND4 Treatment of Leber Hereditary Optic Neuropathy (LHON)
Condition: Leber Hereditary Optic Neuropathy
Intervention: Drug: rAAV2-ND4
38 Not yet recruiting RTA 408 Capsules in Patients With Mitochondrial Myopathy - MOTOR
Condition: MItochondrial Myopathies
Interventions: Drug: RTA 408 capsules, 2.5 mg;   Drug: RTA 408 capsules, 5 mg;   Drug: RTA 408 capsules, 10 mg;   Drug: Placebo capsules
39 Unknown  The Effects of Exercise Versus Inactivity on People With Mitochondrial Muscle Disease
Condition: Mitochondrial Myopathy
Intervention: Behavioral: Exercise
40 Recruiting Trial of Cyclosporine in the Acute Phase of Leber Hereditary Optic Neuropathy
Condition: Leber Hereditary Optic Neuropathy
Intervention: Drug: cyclosporine

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years